“Dovel Technologies, a leading expert to federal agencies that blends deep domain expertise and advanced technologies in the health IT, life sciences, and grants management markets, today announced a major capital investment and partnership with Macquarie Capital, the corporate advisory, capital markets, and principal investment arm of Macquarie Group. The capital infusion will be used to broaden Dovel’s reach within the Federal market in areas including biomedical informatics, scientific research and development, advanced analytics and artificial intelligence, and full lifecycle grants management and administration.”
“Dovel grew a rapid 60 percent annually between 2011 and 2017, transitioning from a small business to a successful mid-tier business with annual revenues of more than $200 million in 2018. This partnership with Macquarie will provide the capital needed for organic and acquisitive growth as the company looks to rapidly advance its innovative development of solutions, services, and capabilities for new and developing customers…” Read the full press release here.
Source: Dovel Technologies Teams with Macquarie Capital to Power Next Phase of Growth – May 6, 2019. Dovel Technologies.
